Castleark Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-46,380
| Closed | -$3.97M | – | 295 |
|
|
2023
Q4 | $3.97M | Buy |
+46,380
| New | +$3.97M | 0.18% | 138 |
|
|
2023
Q3 | – | Sell |
-12,610
| Closed | -$1.07M | – | 294 |
|
|
2023
Q2 | $1.07M | Sell |
12,610
-53,870
| -81% | -$4.59M | 0.05% | 186 |
|
|
2023
Q1 | $5.5M | Sell |
66,480
-29,950
| -31% | -$2.48M | 0.27% | 86 |
|
|
2022
Q4 | $7.58M | Sell |
96,430
-5,910
| -6% | -$465K | 0.4% | 57 |
|
|
2022
Q3 | $7.58M | Buy |
102,340
+19,290
| +23% | +$1.43M | 0.42% | 49 |
|
|
2022
Q2 | $5.41M | Buy |
+83,050
| New | +$5.41M | 0.29% | 84 |
|
|
2020
Q1 | – | Sell |
-82,292
| Closed | -$9.46M | – | 354 |
|
|
2019
Q4 | $9.46M | Sell |
82,292
-32,558
| -28% | -$3.74M | 0.38% | 84 |
|
|
2019
Q3 | $14.5M | Buy |
114,850
+110
| +0.1% | +$13.9K | 0.59% | 39 |
|
|
2019
Q2 | $13.8M | Buy |
+114,740
| New | +$13.8M | 0.53% | 42 |
|
|
2019
Q1 | – | Sell |
-113,412
| Closed | -$11.3M | – | 377 |
|
|
2018
Q4 | $11.3M | Sell |
113,412
-48,810
| -30% | -$4.88M | 0.48% | 54 |
|
|
2018
Q3 | $18.6M | Sell |
162,222
-64,380
| -28% | -$7.38M | 0.53% | 44 |
|
|
2018
Q2 | $20.3M | Sell |
226,602
-7,754
| -3% | -$695K | 0.63% | 36 |
|
|
2018
Q1 | $17.1M | Buy |
234,356
+52,861
| +29% | +$3.87M | 0.54% | 43 |
|
|
2017
Q4 | $10.5M | Buy |
+181,495
| New | +$10.5M | 0.32% | 110 |
|